You just read:

Infinity Presents Initial Clinical And New Preclinical Data On IPI-549 At Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

News provided by

Infinity Pharmaceuticals, Inc.

Sep 26, 2016, 17:15 ET